Biden administration’s decision. But the European Commission president, Ursula von der Leyen, said she did not endorse Mr. Biden’s plan, raising questions about whether the bloc would agree to waive patents. And Germany, the bloc’s de facto leader, said that the U.S. proposal could trigger “significant implications” for the production of vaccines.
“The limiting factor in vaccine manufacturing is production capacity and high quality standards, not patents,” a spokeswoman for Chancellor Angela Merkel of Germany said in the statement.
In her speech, Ms. von der Leyen said that the European Union was “ready to discuss any proposals
Posts from the same category:
- None Found